Thus, the PTEN gene might be a factor in the trastuzumab resistance of gastric cancer, and its downstream PI3K-AKT and bypass IGF-1R signaling pathways might be new targets for clinical research on drug resistance in the future. The gene discussed is IGF1R; the disease is gastric cancer.